Cerebras Systems Inc is an AI company... Show more
Cerebras Systems is an artificial intelligence infrastructure company that designs and manufactures a proprietary AI compute platform delivered in racks for deployment in data centers at up to supercomputer scale. Its flagship product is the Wafer-Scale Engine 3 (WSE-3), a chip roughly the size of a dinner plate that integrates about 4 trillion transistors and 900,000 AI cores on a single wafer. The company's wafer-scale architecture is designed to deliver AI inference speeds more than an order of magnitude faster than conventional GPU-based systems while avoiding reliance on supply-constrained high-bandwidth memory.
Cerebras, founded in 2015 and headquartered in Sunnyvale, California, positions itself as a challenger to GPU-based incumbents in the AI accelerator market. Its customers span hyperscalers, foundation model labs, enterprises, and sovereign AI initiatives. Investors follow the stock closely because of its high-growth AI compute exposure, its landmark OpenAI and AWS partnerships, and the competitive risks it faces against larger, better-capitalized rivals.
Over the last 30 days, CBRS has lost roughly 54% of its value, sliding from a closing price near $177.10 in early October 2026 to about $81.71 in early November. The decline accelerated in the final sessions of the period, with the stock falling more than 11% in a single day as selling pressure intensified.
The last quarter has been even steeper. Around three months ago, shares traded near $211, meaning the stock has dropped approximately 61% over that span. The retreat has been broad and persistent rather than a single-event shock, reflecting a steady unwind of post-IPO enthusiasm as the market reassessed near-term profitability and execution.
Several verified factors have pressured the stock. The most significant is a sharp sequential decline in gross margin guidance. In its first-quarter 2026 results, Cerebras reported revenue of $193.4 million, up 94% year over year, with an adjusted gross margin of 47%. Management subsequently guided second-quarter adjusted gross margin down to between 36% and 38%, citing the cost of temporarily renting back systems from customers while rapidly expanding cloud capacity to support its OpenAI agreement. For full-year 2026, the company expects gross margin between 38% and 41%.
That near-term margin compression, combined with tight data-center capacity and questions around the timing of AWS deployments, has kept profitability and execution risk in focus. Investor caution has also been amplified by the expiration of insider lock-up periods following the company's May 2026 initial public offering, which increased the potential supply of shares available for sale.
The quarterly decline reflects a broader shift in sentiment rather than a single catalyst. Cerebras completed its IPO in May 2026 at $185.00 per share and surged on its debut as investors rewarded its AI infrastructure story, with the stock reaching a 52-week high of $386.34. Since then, enthusiasm has faded as the market has weighed premium valuation against slowing gross margin, ongoing losses, and intense competition from established players such as NVIDIA, Advanced Micro Devices, and Intel.
Customer concentration remains a key risk. Historically, G42 and MBZUAI accounted for the vast majority of annual revenue, while OpenAI is expected to represent a substantial portion of future revenue. Any disruption to these relationships could materially affect results. The positive backdrop—a more than $20 billion OpenAI agreement with an option to expand to 2 gigawatts and roughly $25 billion in remaining performance obligations—has not been enough to offset near-term concerns.
Tickeron's Trending AI Robots page showcases a curated selection of the platform's artificial intelligence trading bots. Tickeron offers hundreds of AI-driven bots that trade across thousands of tickers, but only top-performing and most relevant bots are featured in this section. The bots vary in strategy, timeframe, and performance metrics, allowing traders to explore approaches ranging from short-term signals to longer-horizon positioning. The page is designed to help users identify currently active and high-performing automated strategies across different market conditions. For investors and traders interested in supplementing their research with data-driven, automated insights, exploring the available AI bots can provide an additional perspective on evolving market dynamics.
Cerebras is scheduled to report third-quarter 2026 results in mid-November, and the release will be closely watched for updates on gross margin trajectory, cloud capacity deployment, and progress on the OpenAI and AWS partnerships. Investors should monitor whether the company can hold or improve its margin outlook as its own data centers come online, which would help offset the temporary capacity costs that have weighed on profitability.
Beyond earnings, key factors include the pace of AWS deployment timing, any changes to the OpenAI relationship, customer diversification efforts, and the competitive response from larger chipmakers. Analyst price targets remain substantially above the current share price, but near-term execution on gross margin and capacity will likely determine whether sentiment stabilizes.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CBRS declined for three days, in 28 of 28 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 5 of 5 cases where CBRS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for CBRS just turned positive on November 09, 2026. Looking at past instances where CBRS's MACD turned positive, the stock continued to rise in 1 of 2 cases over the following month. The odds of a continued upward trend are 50%.
Following a +18.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBRS advanced for three days, in 17 of 22 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.327) is normal, around the industry mean (5.443). P/E Ratio (-19.264) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors